Serum-Free Colorectal Stem Cell Culture Medium
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for culturing colorectal epithelial stem cells in vitro are inefficient and unable to maintain stemness, and there is no established protocol for using these cells for repairing damaged tissues in human bowel diseases.
Innovation Solution
A culture medium comprising serum albumin, Wnt3a, and r-spondin-1, with optional EGF, HGF, and Noggin, allows for the long-term maintenance and propagation of colorectal epithelial stem cells in a serum-free environment, which can be administered to damaged colons to enhance recovery from acute colitis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional culture media with serum and multiple growth factors are used, then cell proliferation may be supported, but stemness maintenance fails and culture efficiency is low
Solution Approach 1:
The invention changes the chemical composition parameters of the culture medium by replacing serum-based components with a defined serum-free formulation containing specific concentrations of Wnt3a (50-500 ng/mL), r-spondin1 (10-100 ng/mL), and EGF (10-50 ng/mL). This parameter optimization enables both stemness maintenance and high culture efficiency simultaneously
Solution Approach 2:
The invention creates a composite culture medium system that integrates multiple signaling pathway activators (Wnt, R-spondin, EGF) with a basal medium (DMEM/F12) and extracellular matrix components. This composite formulation synergistically supports both stem cell proliferation and stemness maintenance
2Reliability
If complex culture conditions with multiple components are used, then cell survival may be improved, but manufacturing complexity and cost increase
Solution Approach 1:
The invention extracts and eliminates complex serum components and unnecessary growth factors from conventional culture media, retaining only the essential three components (Wnt3a, r-spondin1, EGF) that are critical for colorectal epithelial stem cell survival. This simplification reduces manufacturing complexity while maintaining cell survival
Solution Approach 2:
The invention defines specific concentration ranges for each component (Wnt3a: 50-500 ng/mL, r-spondin1: 10-100 ng/mL, EGF: 10-50 ng/mL) to optimize cell survival within a simplified formulation, reducing the need for complex medium compositions
3Quantity of substance
If large amounts of tissue are required for culture, then sufficient cell numbers may be obtained, but clinical application becomes difficult
Solution Approach 1:
The invention enables preliminary expansion of colorectal epithelial stem cells in vitro using the optimized culture medium before transplantation. This preliminary culture step allows small biopsy samples (minimal tissue requirement) to generate sufficient cell numbers for clinical therapy
Solution Approach 2:
The enhanced proliferation capability achieved through optimized growth factor concentrations enables rapid cell expansion from minimal starting tissue, generating sufficient cell numbers for clinical applications without requiring large biopsy samples
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described method enables the stable and reproducible culture of colorectal epithelial stem cells, allowing them to engraft and form functional, self-renewable colonic crypts, effectively preventing and treating bowel diseases with reduced costs and minimal tissue requirements.
Implementation Method 1
Wnt3a is a protein encoded by a WNT3A gene and is known to activate the β-catenin pathway. The Wnt/β-catenin pathway is known to be involved in proliferation of stem cells and maintenance of undifferentiation.
Implementation Method 2
R-spondin-1 (Roof-plate-specific Spondin-1: Rspo1) is a protein encoded by an RSPO1 gene and is known to contribute to differentiation of the dorsal neural tube and to enhance the proliferation of intestinal crypt epithelial cells.
Implementation Method 3
An epidermal growth factor (EGF) is a protein encoded by an EGF gene and is known to enhance the proliferation of epithelial cells.
Implementation Method 4
A hepatocyte growth factor (HGF) is a protein encoded by an HGF gene and is known to enhance the proliferation of various cells including hepatocytes.
Implementation Method 5
Noggin is a protein encoded by an NOG gene and is known to inhibit the signaling of transforming growth factor beta (TGF-β).
Data Source
Figure 1a~2b
Figure 3a~3d
Figure 4a~4f
AI summary
It is an object of the present invention to provide a culture medium for in vitro culture of a colorectal epithelial stem cell or the like, a method of in vitro culturing a colorectal epithelial stem cell or the like using the culture medium, a prophylactic or therapeutic agent for a bowel disease containing a colorectal epithelial stem cell or the like cultured by the method, a method of administrating, i.e., transplanting a colorectal epithelial stem cell or the like cultured by the method to a bowel disease patient, and a method of isolating a colorectal epithelial stem cell or the like. The culture medium for in vitro culture of a colorectal epithelial stem cell and/or a colorectal epithelial cell characteristically contains serum albumin, Wnt3a, and r-spondin-1.